Economic evaluation for mass vaccination against COVID-19
Open Access
- 25 May 2021
- journal article
- research article
- Published by Elsevier BV in Journal of the Formosan Medical Association
- Vol. 120, S95-S105
- https://doi.org/10.1016/j.jfma.2021.05.020
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Science and Technology, Taiwan (109-2327-B-002-009)
This publication has 29 references indexed in Scilit:
- Remdesivir for the Treatment of Covid-19 — Final ReportThe New England Journal of Medicine, 2020
- Evolution of the COVID-19 vaccine development landscapeNature Reviews Drug Discovery, 2020
- The potential impact of COVID-19 pandemic on the immunization performance in IndonesiaExpert Review of Vaccines, 2020
- Next-generation vaccine platforms for COVID-19Nature Materials, 2020
- Current global vaccine and drug efforts against COVID-19: Pros and cons of bypassing animal trialsJournal of Biosciences, 2020
- The COVID-19 vaccine development landscapeNature Reviews Drug Discovery, 2020
- Department of ErrorThe Lancet, 2020
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaThe Lancet, 2020
- The value of a statistical life: A meta-analysis with a mixed effects regression modelJournal of Health Economics, 2009
- Valuation of the risk of SARS in TaiwanHealth Economics, 2004